| PRLog Free Press Release | + Bookmark This Page |
Filter News Show All ResultsShow Filtered Results Category - Society (x)Country - United Kingdom (x)State / Province - London (x)City / Town Bromley (To see all cities,Central Central London Chiswick Covent Garden Croydon Docklands Hackney London Richmond Southwark St James's Westminster Wimbledon remove category filter) | ![]() Entegrion CFO named 2009 Top Triangle Area CFO
FOR IMMEDIATE RELEASE
PR Log (Press Release) –
Oct 28, 2009 – Research Triangle Park, N.C. –Richard Martin, CFO of Entegrion, joined forty-four distinguished professionals as Triangle Business Leader and BDO Seidman LLP’s 2009 Top CFOs of the Triangle. The 2009 Top CFO winners were selected out of 140 nominations from the categories of Financial Services, Infrastructure, Real Estate, Tech & Telecom, Business Services, and Products & Services.
The Triangle’s Top CFOs were recognized at the Briar Creek Country Club held on the evening of October 13th. Many of the area’s top CFO’s were in attendance and the keynote speaker for the event was Frank G. Paci, Executive VP of Business Operations, CFO of The Pantry, Inc. “This recognition of Dick Martin’s talents is richly deserved,” said Stan Eskridge, CEO of Entegrion. “Dick has worked tirelessly and brilliantly during the past year to help manage our company through the economic challenges that have impacted our industry. We simply could not continue to make such progress without him.” About Entegrion Entegrion is a life sciences company that selectively integrates synergistic technologies with those in its patent portfolio for development of novel devices and drugs for hemorrhage control, wound management, and associated tissue repair. The company is based in North Carolina’s Research Triangle Park, and is the inventor of Stasilon® – the FDA-cleared, hemostatic and non-adherent medical textile technology approved for use both by prescription and by consumers from which multiple hemorrhage control products are made. Building upon technologies licensed from the University of North Carolina, Entegrion’s portfolio includes platelet-derived as well as plasma-based platform technologies that are being developed as topical gels and sprays for tissue repair, infusible agents for the control of internal hemorrhage and restoration of hemodynamic balance, and novel vehicles for delivery of drugs to targeted tumors and other sites of internal bleeding. For more information, visit http://www.entegrion.com. # # # Entegrion is a life sciences company that selectively integrates synergistic technologies with those in its patent portfolio for development of novel devices and drugs for hemorrhage control, resuscitation, and associated tissue repair. To embed this press release, copy and paste the following HTML code into your webpage-
Email to a Friend Visit Press Room Previous News Next News
Disclaimer: Issuers of the press releases are solely responsible for the content of their press releases. PRLog.Org can't be held liable for the contents of the press releases. Report Abuse Latest Press Releases From “Entegrion”
Upcoming Press Releases...
|
For Businesses ...
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||